Migraine surgery is rarely recommended as a therapy for migraine. Not enough evidence exists to determine who should get it, if it’s effective, and the long-term risks. Speak with your doctor ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...
The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...
"She had a continuous migraine for 48 days," Moulton said ... which aims to create more space for the cerebellum and relieve pressure on the spinal cord. This surgery can alleviate symptoms like ...
Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white ...
if you have the condition known as chronic migraine, you get headaches 15 or more days a month for at least 3 months. These headaches happen more than 15 days each month for at least 3 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback